MYSTAGE DX
LIVE

Serial Number

99535289

Owner

Spotlight Medical

Attorney

Patrick J. Jennings

Filing Date

Dec 8, 2025

Add to watchlist:

No watchlists yet
View on USPTO

MYSTAGE DX Trademark

Serial Number: 99535289

MYSTAGE DX is a trademark filed by Spotlight Medical on December 8, 2025. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Spotlight Medical (2 trademarks)

29 Rue Du Faubourg Saint-Jacques
Paris 75014 , FR

Entity Type: 34

Trademark Details

Filing Date

December 8, 2025

Registration Date

Not Registered

Published for Opposition

September 8, 2026

Goods & Services

Biological data sets in the field of biomarkers, namely, diagnostic biomarkers in digital form recorded on computer media, for medical purposes; Biological data sets in the field of biomarkers, namely, diagnostic biomarkers in digital form recorded on computer media, for determining cancer treatment; all the foregoing obtained via artificial intelligence (AI) processing of biological data

Online non-downloadable medical diagnostic software that allows users to detect, diagnose, and treat cancer, in the field of cancer treatment; Online non-downloadable medical screening software that allows users to detect, diagnose, and treat cancer, in the field of cancer treatment

Medical diagnostic services in the field of cancer treatment; Medical screening services in the field of cancer treatment

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 14, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 14, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 14, 2026 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 14, 2026 ERFR
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Aug 13, 2026 RDX3
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Aug 13, 2026 RDX1
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Aug 13, 2026 RRDX
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 12, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 12, 2026 CRFA
ASSIGNED TO LIE
Aug 12, 2026 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 10, 2026 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 6, 2026 GNFN
FINAL REFUSAL E-MAILED
Aug 6, 2026 GNFR
FINAL REFUSAL WRITTEN
Aug 6, 2026 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 20, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 20, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 20, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 16, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jul 16, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jul 16, 2026 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 23, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 23, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 23, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 16, 2026 GNRN
NON-FINAL ACTION E-MAILED
Apr 16, 2026 GNRT
NON-FINAL ACTION WRITTEN
Apr 16, 2026 CNRT
ASSIGNED TO EXAMINER
Apr 11, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 12, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Dec 8, 2025 MAFR
NEW APPLICATION ENTERED
Dec 8, 2025 NWAP